| Literature DB >> 36187349 |
Penghui Chen1,2,3, Wenjin Wu1,2,3, Jifang Zhang1,2,3, Junmin Chen1,2,3, Yue Li1,2,3, Lianhua Sun1,2,3, Shule Hou1,2,3, Jun Yang1,2,3.
Abstract
Hereditary deafness is one of the most common human birth defects. GJB2 gene mutation is the most genetic etiology. Gap junction protein 26 (connexin26, Cx26) encoded by the GJB2 gene, which is responsible for intercellular substance transfer and signal communication, plays a critical role in hearing acquisition and maintenance. The auditory character of different Connexin26 transgenic mice models can be classified into two types: profound congenital deafness and late-onset progressive hearing loss. Recent studies demonstrated that there are pathological changes including endocochlear potential reduction, active cochlear amplification impairment, cochlear developmental disorders, and so on, in connexin26 deficiency mice. Here, this review summarizes three main hypotheses to explain pathological mechanisms of connexin26-related hearing loss: potassium recycling disruption, adenosine-triphosphate-calcium signaling propagation disruption, and energy supply dysfunction. Elucidating pathological mechanisms underlying connexin26-related hearing loss can help develop new protective and therapeutic strategies for this common deafness. It is worthy of further study on the detailed cellular and molecular upstream mechanisms to modify connexin (channel) function.Entities:
Keywords: cochlea; connexin; gap junction; hearing loss; mechanism
Year: 2022 PMID: 36187349 PMCID: PMC9520402 DOI: 10.3389/fnmol.2022.976388
Source DB: PubMed Journal: Front Mol Neurosci ISSN: 1662-5099 Impact factor: 6.261
FIGURE 2Schematic diagrams of glucose transport in the stria vascularis and spiral ligament of the cochlea.
FIGURE 1Schematic diagrams of Cx expression, potassium recycling, and ATP-Ca2+ signaling in the inner ear.